Clinical Study of ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Advanced Liver Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03965546

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:12.087996+00:00

Published At

2019-08-08T00:00:00+00:00

Record Updated At

2019-08-08

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hepatocellular Carcinoma", "Liver Cancer", "Liver Neoplasms", "Metastatic Liver Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2019-08-08"

protocolSection.identificationModule.nctId

"NCT03965546"

protocolSection.identificationModule.officialTitle

"Clinical Study of ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Advanced Liver Cancer"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["EARLY_PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
• Liver Cancer (protocolSection.conditionsModule.conditions)
• Liver Neoplasms (protocolSection.conditionsModule.conditions)
• Metastatic Liver Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.